DK174066B1 - Fremgangsmåde til fremstilling af et faktor VIII-præparat - Google Patents

Fremgangsmåde til fremstilling af et faktor VIII-præparat Download PDF

Info

Publication number
DK174066B1
DK174066B1 DK198503981A DK398185A DK174066B1 DK 174066 B1 DK174066 B1 DK 174066B1 DK 198503981 A DK198503981 A DK 198503981A DK 398185 A DK398185 A DK 398185A DK 174066 B1 DK174066 B1 DK 174066B1
Authority
DK
Denmark
Prior art keywords
viii
solution
per
factor viii
preparation
Prior art date
Application number
DK198503981A
Other languages
Danish (da)
English (en)
Other versions
DK398185D0 (da
DK398185A (da
Inventor
Norbert Heimburger
Wilfried Wormsbaecher
Gerhardt Kumpe
Original Assignee
Aventis Behring Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6244387&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK174066(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aventis Behring Gmbh filed Critical Aventis Behring Gmbh
Publication of DK398185D0 publication Critical patent/DK398185D0/da
Publication of DK398185A publication Critical patent/DK398185A/da
Application granted granted Critical
Publication of DK174066B1 publication Critical patent/DK174066B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • External Artificial Organs (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Conductive Materials (AREA)
  • Glass Compositions (AREA)
DK198503981A 1984-08-31 1985-08-30 Fremgangsmåde til fremstilling af et faktor VIII-præparat DK174066B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19843432083 DE3432083A1 (de) 1984-08-31 1984-08-31 Pasteurisierte, isoagglutininfreie faktor viii-praeparation und verfahren zu ihrer herstellung
DE3432083 1984-08-31

Publications (3)

Publication Number Publication Date
DK398185D0 DK398185D0 (da) 1985-08-30
DK398185A DK398185A (da) 1986-03-01
DK174066B1 true DK174066B1 (da) 2002-05-21

Family

ID=6244387

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198503981A DK174066B1 (da) 1984-08-31 1985-08-30 Fremgangsmåde til fremstilling af et faktor VIII-præparat

Country Status (8)

Country Link
EP (1) EP0173242B2 (fr)
JP (1) JPS6160614A (fr)
AT (1) ATE73666T1 (fr)
CA (1) CA1265051A (fr)
DE (2) DE3432083A1 (fr)
DK (1) DK174066B1 (fr)
ES (1) ES8702146A1 (fr)
IL (1) IL76260A (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4952675A (en) * 1985-02-01 1990-08-28 New York University Method for purifying antihemophilic factor
US4847362A (en) * 1985-02-01 1989-07-11 New York University Method for purifying antihemophilic factor
US4743680A (en) * 1985-02-01 1988-05-10 New York University Method for purifying antihemophilic factor
CA1339946C (fr) * 1987-03-31 1998-07-07 Michael J. Griffith Methode d'ultrapurification pour les polypeptides
DE3878227D1 (de) * 1988-05-27 1993-03-18 Centre Regional De Transfusion Verfahren zur herstellung eines hochreinen, virusfreien antihaemophiliefaktors mittels chromatographie.
AU2684488A (en) 1988-06-27 1990-01-04 Carter-Wallace, Inc. Test device and method for colored particle immunoassay
EP0367840B1 (fr) 1988-11-05 1993-02-03 Octapharma AG Procédé de préparation d'un facteur antihémophilique non infectieux et de grande pureté par chromatographie
DE3926034C3 (de) * 1989-08-07 1996-11-21 Behringwerke Ag Verfahren zur Herstellung eines stabilen Faktors VIII
DE4001451A1 (de) * 1990-01-19 1991-08-01 Octapharma Ag Stabile injizierbare loesungen von faktor viii und faktor ix
DE4143678B4 (de) * 1991-02-27 2005-03-10 Holland Letz Felo Werkzeug Halter für Schraubendreher-Einsätze
AT402891B (de) * 1991-06-20 1997-09-25 Immuno Ag Verfahren zur herstellung eines inaktivierten blutproduktes
FR2681867B1 (fr) 1991-09-26 1993-12-31 Pasteur Merieux Serums Vaccins Procede de purification du facteur viii et preparations obtenues.
AT399818B (de) * 1992-04-24 1995-07-25 Immuno Ag Verfahren zur herstellung einer hochgereinigten virussicheren faktor viii-präparation
AU6653094A (en) * 1992-12-16 1994-07-04 Immuno Aktiengesellschaft Process for preparing a virus-safe biological composition
DE4320294A1 (de) * 1993-06-18 1994-12-22 Immuno Ag Verwendung von humanem Protein C zur Verhinderung und Behandlung von Thrombozytenablagerungen
DE4337573C1 (de) * 1993-11-04 1995-05-18 Octapharma Ag Verfahren zur Herstellung einer virusinaktivierten Faktor VIII enthaltenden Fraktion mittels chromatographischer Methoden
DE19802007C1 (de) * 1998-01-20 1999-11-11 Wacker Werke Kg Sicherheitsanordnung für die Bedienungselemente einer handgeführten Bodenverdichtungswalze
DE102004009400A1 (de) 2004-02-24 2005-09-08 Zlb Behring Gmbh Fibrinogen Reinigung
CN102295696B (zh) * 2011-08-16 2013-06-26 山东泰邦生物制品有限公司 由冷沉淀制备凝血因子ⅷ、纤维蛋白原和纤维结合蛋白的方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2653534C2 (de) * 1975-12-22 1986-08-28 Baxter Travenol Laboratories, Inc., Deerfield, Ill. Feste Antihämophilen-Faktor-Präparation und Verfahren zu ihrer Herstellung
DE2635894A1 (de) * 1976-08-10 1978-02-16 Biotest Serum Institut Gmbh Verfahren zur herstellung eines antihaemophiles globulin a enthaltenden konzentrats
JPS57136526A (en) * 1981-02-17 1982-08-23 Green Cross Corp:The Preparation of blood coagulation factor 8
AU555305B2 (en) * 1982-09-29 1986-09-18 Bayer Corporation Antihemophilic factor concentrate
DE3237512A1 (de) * 1982-10-09 1984-04-12 Behringwerke Ag, 3550 Marburg Verfahren zur pasteurisierung von antihaemophilem kryopraezipitat (ahk) und danach hergestelltes antihaemophiles kryopraezipitat
US4508709A (en) * 1983-12-05 1985-04-02 Armour Pharmaceutical Company Process for purifying factor VIII:C

Also Published As

Publication number Publication date
DK398185D0 (da) 1985-08-30
DE3585649D1 (de) 1992-04-23
DK398185A (da) 1986-03-01
JPS6160614A (ja) 1986-03-28
IL76260A0 (en) 1986-01-31
EP0173242A3 (en) 1987-10-07
ES546526A0 (es) 1986-12-16
ATE73666T1 (de) 1992-04-15
CA1265051A (fr) 1990-01-30
EP0173242A2 (fr) 1986-03-05
EP0173242B1 (fr) 1992-03-18
JPH0580455B2 (fr) 1993-11-09
EP0173242B2 (fr) 1996-07-24
ES8702146A1 (es) 1986-12-16
DE3432083A1 (de) 1986-03-06
IL76260A (en) 1992-02-16

Similar Documents

Publication Publication Date Title
DK174066B1 (da) Fremgangsmåde til fremstilling af et faktor VIII-præparat
US6239261B1 (en) Pasteurized, purified von Willebrand factor concentrate and a process for the preparation thereof
EP0176926B1 (fr) Procédé de production d'un concentrat de facteur antihémophilique de haute pureté
NO177188B (no) Fremgangsmåte for separering av humane eller animalske plasmaproteiner
DK155568B (da) Fremgangsmaade til stabilisering af koagulationsfaktorerne ii, viii, xiii og antithrombin iii samt plasminogen, og saaledes at disse er fibrinogen-fri og fri for risiko for en hepatitis-overfoering
DK162896B (da) Fremgangsmaade til oprensning af factor viii:c samt farmaceutisk praeparat indeholdende denne
EP0468181A2 (fr) Procédé pour la purification du facteur VIII et facteur VIII obtenu par ledit procédé
US4562072A (en) Process for the pasteurization of antihemophilic cryoprecipitate (AHC) and antihemophilic cryoprecipitate prepared thereby
Hoffman Purification and large-scale preparation of antithrombin III
EP0252392B1 (fr) Inactivation virale et purification de protéines actives
US4814435A (en) Method of producing a factor VIII (AHF) containing fraction
US4774323A (en) Purification of von Willebrand Factor solutions using gel permeation chromatography
JP2511631B2 (ja) 因子ｖｉｉｉ製品の製造方法
WO1993010143A1 (fr) Stabilisation du facteur antihemophile
EP0600480B1 (fr) Procédé d'extraction de facteur VIII-von willebrand facteur (FVIII:C-FVW) complexe à partir de plasma humain
AU752271B2 (en) Method for preparing by filtration a virally secure factor VIII solution
US5043428A (en) Pasteurized, isoagglutinin-free factor VIII preparation and a process for its production
AU635535B2 (en) Gel filtration of heat treated factor viii
EP0221566B1 (fr) Procédé de préparation du facteur antihémophilique (AHF) par précipitation par le froid et d'amélioration de la solubilité de l'AHF receuilli
US4822872A (en) Method of purifying factor VIII
US5006642A (en) Purification of von Willebrand Factor by affinity chromatography
JPS61189228A (ja) 血液凝固第８因子製剤の製法
US4302445A (en) Method for concentrating and purifying antihemophilic factor or factor VIII
Ng et al. Preparation of high purity factor VIII concentrates
Branović et al. Characterization of F VIII concentrates produced by two methods incorporating double virus inactivation

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed

Country of ref document: DK